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Prostate gene expression <p>Microarray analyses to quantitate transcript levels in the prostates of five inbred mouse strains identified differences in gene expression  in benign epithelium that correlated with the differentiation state of adjacent tumors.</p>
Abstract
Background:  Cancer of the prostate is influenced by both genetic predisposition and
environmental factors. The identification of genes capable of modulating cancer development has
the potential to unravel disease heterogeneity and aid diagnostic and prevention strategies. To this
end, mouse models have been developed to isolate the influences of individual genetic lesions in
the context of consistent genotypes and environmental exposures. However, the normal prostatic
phenotypic variability dictated by a genetic background that is potentially capable of influencing the
process of carcinogenesis has not been established.
Results: In this study we used microarray analysis to quantify transcript levels in the prostates of
five commonly studied inbred mouse strains. We applied a multiclass response t-test and
determined that approximately 13% (932 genes) exhibited differential expression (range 1.3-190-
fold) in any one strain relative to other strains (false discovery rate ≤10%). Expression differences
were confirmed by quantitative RT-PCR, or immunohistochemistry for several genes previously
shown to influence cancer progression, such as Psca, Mmp7, and Clusterin. Analyses of human
prostate transcripts orthologous to variable murine prostate genes identified differences in gene
expression in benign epithelium that correlated with the differentiation state of adjacent tumors.
For example, the gene encoding apolipoprotein D, which is known to enhance resistance to cell
stress, was expressed at significantly greater levels in benign epithelium associated with high-grade
versus low-grade cancers.
Conclusion: These studies support the concept that the cellular, tissue, and organismal context
contribute to oncogenesis and suggest that a predisposition to a sequence of events leading to
pathology may exist prior to cancer initiation.
Background
Family history and race represent two of the greatest contrib-
utors to the probability of developing cancer of the prostate.
Recent estimates suggest that 42% of prostate cancer risk
may be attributed to heritable factors that include the influ-
ence of rare alleles capable of exerting substantial effects,
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common alleles with weak effects, and gene interactions that
act to amplify or buffer phenotypes [1]. Racial background
accounts for disparities of more than 40-fold in the incidence
of prostate cancer between Western and Asian men, and also
associates with cancer progression and lethality [2]. Impor-
tantly, risks attributed to racial categories may reflect not
only genetic variables, but also a myriad of shared environ-
mental exposures that include diet, infectious disease, and
medication use.
Cancer susceptibility represents a continuum of interactions
between the host and environment. At the extremes, each can
exert dominant effects on the neoplastic process. For exam-
ple, inherited differences in specific gene products, such as
p53, Rb, and APC, lead to the near-universal development of
cancers, regardless of differences in the host environment [3].
Similarly, exposures to ionizing radiation or chemical muta-
gens can produce high rates of neoplasia regardless of the
host genetic background. However, most human malignan-
cies cannot be attributed to specific genes or extrinsic agents
that exert dominant effects, but rather arise in the setting of
complex multi-factorial gene-environment relationships. In
this context, studies of twins have found that genetic back-
ground is associated with a large proportion of supposedly
nonhereditary cancers, a finding supported by the familial
clustering of specific malignancies [1].
The identification of low-penetrance genetic modifiers that
influence cancer phenotypes has been challenging in humans
due to substantial genetic heterogeneity and the inability to
identify, quantify and control for a wide-range of environ-
mental variables. Furthermore, tumors arising in specific
organ sites may exhibit multiple different histologies that
include differentiation state and the propensity to progress at
variable rates [4,5]. To overcome these hurdles, inbred
strains of model organisms such as the mouse have been used
to control environmental influences, homogenize tumor his-
tologies, and reduce the complexity of genetic backgrounds
[6]. Manipulating these variables has facilitated studies that
link genomic loci with the propensity to develop neoplasia
and the identification of genes that modulate tumor behavior.
Despite highly similar genomes, striking differences in tum-
origenesis and metastasis have been observed in different
rodent strains induced to develop cancers of the lung, breast,
intestine, skin, and prostate [7-11]. Breeding strategies
designed to isolate the genes responsible for cancer suscepti-
bility have successfully identified modifying loci [12]. The
characterization of specific genes modulating cancer pheno-
types indicates that carcinogenesis is influenced by tumor-
intrinsic features as well as variables in the host macro- and
microenvironments [13]. Intrinsic cellular properties include
proliferation rates, genome stability, differentiation potential
and the ability to senesce or undergo apoptosis. Tumor-
'extrinsic' factors that influence the process of carcinogenesis
include hormone concentrations, immune response, drug
metabolism, and features of the local stroma involving matrix
and neovascularization. Importantly, many cancer-modifying
loci exhibit multiple genetic interactions that suggest the
existence of molecular networks that underlie cancer predis-
position [6,7].
Studies of prostate carcinogenesis in rodent models devel-
oped using chemical mutagens or gene-targeting strategies
have clearly demonstrated modifications of cancer incidence
and progression rates dependent on the host genotype. The
substantial tumor-promoting or tumor-suppressing effects
exerted by innate host factors suggests that features of benign
tissues could allow the behavior of tumor growth to be pre-
dicted. To support this hypothesis, influential biochemical or
tis su e v ar iat ion s mu st occur and must exhibit measurable
characteristics. While variations in immune effectors and
hormone levels represent likely influences on prostate car-
cinogenesis in these model systems, differences intrinsic to
the prostate gland could also account for tumor incidence
rates between strains. One measurement of phenotypic
potential involves the identification and quantification of cel-
lular gene transcription.
To date, global analyses of gene expression in the normal
prostate gland of mouse strains have not been reported. In
this study, we used microarray analysis to profile prostate
gene expression across five inbred mouse strains commonly
used for modeling prostate development and carcinogenesis.
We found substantial strain-dependent differences in pros-
tate transcript expression patterns, including several genes
implicated in prostate cancer development and progression.
Analyses of these strain-variable genes in the human prostate
enabled the determination of associations between transcript
expression levels and phenotypes of prostate cancer, such as
tumor grade. The results indicate that variables in prostate
gene expression present prior to cancer initiation could mod-
ify tumorigenesis.
Results and discussion
Determination of strain-specific differences in mouse 
prostate gene expression
Several studies have demonstrated the influence of genetic
background on the development and progression of prostate
cancer in rodents. Using a genetically engineered mouse
model driving SV40T antigen expression in the prostate
gland, designated TRAMP, Gingrich et al. [14] determined
that prostate tumors arising in a mixed C57BL/6 × FVB back-
ground display reduced latency, increased primary tumor
growth and enhanced metastatic progression when compared
to tumor development in a pure C57BL/6 background. A
recent study of Pten deficient mice reported a critical role for
genetic background that influenced the onset, tumor spec-
trum, and progression rates for cancers that included pros-
tate carcinoma [15]. Strain-specific effects have also been
observed in mice with inactivation of the prostate-specific
Nkx3.1  homeobox gene: the occurrence of intraepithelialhttp://genomebiology.com/2007/8/6/R117 Genome Biology 2007,     Volume 8, Issue 6, Article R117       Bianchi-Frias et al. R117.3
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neoplasia was more frequent in C57BL/6 and FVB/N strains
than in the 129/SvImJ background (Cory Abate-Shen, per-
sonal communication). Genetic background has also been
reported to influence transgenic models of rat prostate car-
cinogenesis, with cancer incidence rates ranging from 0% to
83%, depending on strain background [11].
To ascertain the extent of gene expression variability in the
normal prostate arising in the context of different genetic
backgrounds, we used cDNA microarray analysis to measure
transcript abundance levels for approximately 8,300 genes in
the prostate glands of five frequently studied strains of Mus
musculus; C57BL/6, 129X1/Sv, BALB/c, FVB/N and DBA/2.
Four biological replicates consisting of tissues pooled from
groups of three individuals were generated to facilitate statis-
tical analyses and control for individual variability (Figure 1).
We employed a common reference pool design to control for
technical differences in array construction and hybridization.
The transcript level of each gene was measured as the ratio of
the intensity of hybridization signal for a strain-specific
experiment relative to that for the reference pool.
To determine the extent and magnitude of prostate gene
expression variation between strains, we generated a one-way
ANOVA table for each gene and compared the within-strain
mean square (intra-strain replicates) to the between-strain
mean square. As expected, the vast majority of genes exhib-
ited low variance across the 20 array experiments. Further-
more, few differences were observed in the intra-strain
comparisons, a result likely influenced by the pooling of sam-
ples to minimize the contribution of any individual mouse.
However, comparisons of gene expression between strains
identified substantial reproducible differences in the expres-
sion of many genes (range from 1.3 to 190-fold; Figure 2a).
We used significance analysis of microarrays (SAM) proce-
dures and applied a multiclass response t-test to identify
genes whose expression in one strain significantly differed
from the other four strains. Approximately 13% of the genes
(932 genes) exhibited significant differential expression given
a moderate estimate of false positive differences of 10%. The
heat map revealed that the pattern of variability in transcript
levels did not result from variations unique to a particular
strain, but rather represents genetic variability across all five
strains assessed (Figure 2b).
To explore the relationships between strains, we performed
average linkage hierarchical clustering using all the genes
(data not shown) and then using only the 932 genes that were
differentially expressed between strains as determined by the
SAM analysis (Figure 2b). The resulting dendrograms are
identical, indicating that strain specific variation is not
entirely explained by a small number of genes exhibiting large
changes in gene expression. The expression patterns derived
from prostates of the same strain are highly concordant and
produce a consistent grouping of samples according to their
strain of origin (Figure 2b). Overall, the samples are divided
into three major branches: branch I is represented by BALB/
c; branch II is represented by C57BL/6 and DBA/2; and
branch III is represented by 129X1/Sv and FVB/N. Further-
more, within each branch, sub-branches clearly grouped
pools according to strain.
In order to further characterize the relationship between
strains, we performed principal components analysis (PCA)
using the 932 differentially expressed genes (Figure 2c). The
first four components explained 70% of the total variance. As
expected, each of these informative components identified a
subset of genes that discriminated between at least two of the
strains. Taken together, these results show that strain-spe-
cific variation results from the differential expression of large
numbers of genes and that this signal is stronger than the
within-strain variability when using sample pools.
Experimental design Figure 1
Experimental design. Prostates from 12 mice from each of 5 strains of Mus 
musculus (C57BL/6, 129X1/Sv, BALB/c, FVB/N and DBA/2) were resected 
and individual lobes were dissected: DP, dorsal prostate; LP, lateral 
prostate; VP, ventral prostate; AP, anterior prostate. Each experimental 
sample represents a pool of equal amounts of RNA for each prostatic lobe 
from three animals. Four independent experimental samples were created 
per strain: 12 mice divided into 4 pools of 3 mice each for a total of 4 
microarray experiments per strain. Amplified RNA from each 
experimental sample was hybridized against a reference pool onto custom 
mouse prostate cDNA microarrays using alternate dye-labeling to account 
for dye-specific effects.
Strain A: 12 mice
3 mice/pool 
Combine equal amounts of total RNA from 
each prostatic lobe pool
mRNA amplification
Pool 1 Pool 2 Pool 3 Pool 4
Cy5 Cy3
Pool of each prostatic lobe from 3 mice 
Hybridization to mPEDB microarray
Comparative analysis between the five strains:
BALB/c, C57BL/6, 129X1/Sv, FVB/N and DBA/2. 
Separate dissections of prostatic lobes:
DP, LP, VP and AP
Pool 1 Pool 2 Pool 3 Pool 4
total RNA extraction
Repeat for each strainR117.4 Genome Biology 2007,     Volume 8, Issue 6, Article R117       Bianchi-Frias et al. http://genomebiology.com/2007/8/6/R117
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Among the expressed genes, those encoding pituitary tumor-
transforming 1 (Pttg1) and adenylate cyclase-associated pro-
tein 1 (Cap1)  were found to be differentially expressed
between prostates of C57BL/6 and 129X1/Sv strains. Previ-
ous studies have found concordant strain-dependent differ-
ences in the expression of these genes in other mouse tissues
[16]. Transcripts encoding several members of the histocom-
patibility complex also exhibited strain-dependent differ-
ences. Relative to other strains, H2-Ea is expressed highly in
prostates of DBA/2 and BALB/c mice; H2-k is expressed
highly in 129X1/Sv and C57BL/6; H2-Q1 is expressed highly
in 129X1/Sv, FVB/N and C57BL/6; and transcripts encoding
Prostate gene expression differences among strains Figure 2
Prostate gene expression differences among strains. (a) Scatter plot of variance in gene expression levels between strains and within strains. (b) Average-
linkage hierarchical clustering for the 932 differentially expressed genes among the five mouse strains (FDR <10%). Heat map colors reflect fold ratio 
values between sample and reference pool and mean-centered across samples. Columns represent biological replicates for each strain. Rows represent 
individual genes. Values shown in red are relatively larger than the overall mean; values shown in green are relatively smaller than the overall mean (see 
scale). Genes whose expression changes were confirmed by qRT-PCR, western blot or immunohistochemistry are listed. (c) Separation of the five strains 
in three-dimensional principal component space by applying PCA to the 932 genes with strain variance.
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H2-D1 were least abundant in the C57BL/6 strain. Interest-
ingly, the pattern of expression of this gene family did not
correlate with the known H2 haplotypes of the strains, a find-
ing also reported in a study evaluating strain-specific gene
expression variation in the mouse hippocampus [17].
To identify differentially expressed genes unique to individ-
ual strains, we performed a pair-wise comparison of tran-
script abundance levels between each strain for a total of 10
pair-wise comparisons. The number of genes found to be dif-
ferentially expressed between any two strains varied depend-
ing on the strains compared (Table 1). Strains 129X1/Sv and
FVB/N exhibit the fewest differences in prostate gene expres-
sion (88 genes) whereas strains FVB/N and C57BL/6 exhibit
the greatest number of transcript abundance differences (237
genes). Analyses of the promoter regions of these strain-vari-
able genes did not identify sequence motifs that would sug-
gest common regulatory mechanisms.
Confirmation of strain-dependent differences in 
prostate gene expression
Several genes exhibiting strain-dependent differences in
prostate expression have been studied in the context of pros-
tate development (for example, Sbp), androgen regulation
(Fabp5,  Odc), tumorigenesis (for example, Psca,  Azgp1,
Apod, Mmp7, Egf, Mgst1, Clusterin), and the progression of
metastatic cancer (Cxcl12, B2m, H2 family members) [8]. To
confirm the microarray results, we selected several of these
genes for analysis by quantitative real-time reverse-transcrip-
tion PCR (qRT-PCR). Primer pairs specific to Svs2,  Psca,
Mmp7, Spb and Clusterin were used to quantify transcripts in
the same RNA samples used in the microarray experiments
(Figure 3a; Figure 4a for clusterin). We measured transcripts
encoding the housekeeping gene encoding ribosomal protein
S16 to normalize the qRT-PCR data. From the microarray
results, S16 expression did not vary significantly between
strains.
Overall, the qRT-PCR transcript measurements for the five
genes tested were in good agreement with the microarray
data, though the magnitude of relative fold differences in the
qRT-PCR assay was greater compared to the microarray
results. This observation is partly due to intrinsic limitations
in the microarray experimental design, where transcript lev-
els were measured as the ratio between an experimental sam-
ple (strain sample) relative to that for the reference sample
(pool of all strains). The expression of Mmp7 varied between
5- and 15-fold between strains with the greatest difference
observed in a comparison of 129X1/Sv and DBA/2 mice (Fig-
ure 3a). The expression of Psca varied up to 40-fold between
strains and the expression of Clusterin was at least 70-fold
greater in the FVB/N mice relative to any other strain.
Assessments of strain-associated variation in prostate 
cellular composition and cell type-specific gene 
expression
We hypothesized that strain-specific disparities in the ratios
of cell types within the prostate gland could be reflected as
measurable differences in transcript levels. The rodent pros-
tate is composed principally of luminal secretory epithelium,
basal epithelium, and a stroma consisting primarily of fibrob-
lasts and smooth muscle, with a smaller component of
endothelium, nerve cells, neuroendocrine cells, and inflam-
matory infiltrates. Since our transcript profiling studies were
performed using whole prostates containing mixtures of the
various cell types, we could not exclude the possibility that
differences in gene expression between strains were a result
of differences in cell type ratios between strains. To address
this, we performed an ad hoc analysis using two prostates per
strain, and calculated the percentage of prostate area occu-
pied by stroma and epithelium for each lobe. Based on the
estimated effect sizes and the corresponding p values, we did
not identify significant strain-associated differences in the
ratios of cell types between strains (data not shown).
To further confirm that prostate gene expression differences
arise from intrinsic genetic variation and not cell ratio effects,
we microdissected secretory epithelium from two strains:
C57BL/6 and 129X1/Sv. We measured the transcript levels
for two genes, Sbp and Mmp7, that exhibited strain-associ-
ated differences in the microarray studies. As shown in Figure
3b, transcript levels of Mmp7 and Sbp were four-fold higher
and four-fold lower, respectively, in microdissected epithe-
lium from 129X1/Sv relative to C57BL/6. These findings are
in agreement with the differences in transcript levels
observed for these genes in the analyses of whole prostates
from these strains (compare Figures 3a and 3b). Together,
these results support the conclusion that differences in
Table 1
Pairwise comparisons of mouse prostate gene expression between strains of Mus musculus
Strain C57BL/6 129X1/Sv FVB/N BALB/c DBA/2
129X1/Sv 124* - 88 102 116
FVB/N 237 88 - 172 226
BALB/c 173 102 172 - 196
DBA/2 198 116 226 196 -
*Values represent the number of genes with significant differences in transcript abundance measurements between strains. Significance was defined 
as a SAM gene-specific q-value less than 0.05.R117.6 Genome Biology 2007,     Volume 8, Issue 6, Article R117       Bianchi-Frias et al. http://genomebiology.com/2007/8/6/R117
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prostate gene expression between strains, at least for the
genes independently assessed in microdissected epithelium,
represent an intrinsic cellular property rather than possible
differences in prostatic cell type ratios between strains. Fur-
thermore, the experimental design and microarray methods
are capable of identifying transcript abundance differences
between strains for genes expressed in a cell type- and lobe-
specific manner (for example, Sbp [18,19]), even when diluted
by mRNAs from all lobes and multiple cell types. However, it
is likely that subtle, yet biologically relevant alterations in
constituents of the stroma and glandular microenvironment
also exist between strains. Identifying these differences will
likely require detailed cell type-specific assays.
Strain-associated differences in prostate protein 
expression
We next sought to determine if strain-associated differences
in prostate transcript levels were reflected by concordant dif-
ferences in protein expression. We chose to evaluate protein
levels of clusterin, which is encoded by a gene studied exten-
sively in the context of prostate carcinogenesis and therapy
resistance [20-22]. Clusterin, also known as testosterone-
repressed prostate message 2 (TRPM-2) ,  i s  o f  p a r t i c u l a r
interest in view of active efforts to target its expression as a
treatment for human prostate cancer [20]. Although the func-
tion(s) of clusterin remains somewhat enigmatic, recent stud-
ies indicate that antiapoptotic effects are mediated in part
through direct interactions with activated Bax [22]. We have
previously shown that clusterin expression is increased in
Analysis of strain-dependent differences in prostate gene expression by qRT-PCR Figure 3
Analysis of strain-dependent differences in prostate gene expression by qRT-PCR. RNAs from preparations used in the (a) microarray analysis or (b) 
microdissected epithelium were reverse transcribed and amplified using qRT-PCR with primers specific for seminal vesicle secretion 2 (Svs2), matrix 
metallopeptidase 7 (Mmp7), prostate stem cell antigen (Psca) and spermine binding protein (Sbp). Ribosomal protein S16 expression levels were used to 
normalize qRT-PCR data. Normalized results are expressed relative to the lowest expressing value. Error bars indicate the standard deviation of four 
biological independent replicates. qRT-PCR for microdissected epithelium is represented by one sample per strain for each gene. White bars denote 
measurements from the microarray analysis. Black bars denote measurements generated by qRT-PCR from whole prostate. Diagonal lines denote 
measurements generated by qRT-PCR from microdissected prostate epithelium.
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tumors developing in mice with a prostate specific deletion of
the  Pten  tumor suppressor gene [23]. Microarray
hybridization and qRT-PCR quantified clusterin transcripts
at levels ten-fold or greater in prostates of FVB/N mice rela-
tive to all other strains (Figure 4a). A western blot analysis
using ventral prostate protein extracts detected higher clus-
terin levels in prostates of the FVB/N strain when compared
with DBA/2 and C57BL/6 strains (Figure 4b). We next per-
formed immunohistochemistry to determine the cellular
localization of clusterin expression. With the exception of the
ventral lobe, we did not detect major differences in clusterin
expression between mouse strains. However, substantially
greater clusterin immunoreactivity was observed in the secre-
tory epithelium of the ventral lobe of the FVB/N strain, rela-
tive to any other lobe and all other strains. Staining was
particularly intense in the apical region of the epithelium,
suggesting that the secretory form of clusterin is the predom-
inant differentially expressed isoform in FVB/N ventral pros-
tate epithelium (Figure 4c,d). Based on these results, we
speculate that elevated clusterin levels may contribute to the
enhanced rate of prostate tumor development and progres-
sion observed in the TRAMP FVB/N genotype.
Biological pathway analysis of mouse prostate gene 
expression profiles
The substantial number of genes found to be differentially
expressed in the prostates of different mouse strains sug-
gested that specific groups of genes could share common reg-
ulatory mechanisms or participate in particular functional
pathways. To address this possibility, we focused on differ-
ences between the C57BL/6 strain relative to other strains
due to the reduced tumorigenicity observed in transgenic
mouse prostate cancer models arising in the C57BL/6 back-
ground [14,15,24]. We used a method termed 'gene set test'
(GST) in BioConductor that is analogous to the recently
described gene set enrichment analysis (GSEA) algorithm
[25] to determine if genes displaying relative differences in
prostates of C57BL/6 mice were enriched in a database of bio-
logically defined gene sets assembled by the Gene Ontology
(GO) consortium. Only three of 258 gene sets, NADH dehy-
drogenase activity, NADH dehydrogenase (ubiquinone)
activity, and phosphoinositide binding were statistically
enriched in the C57BL/6 prostates (false discovery rate (FDR)
≤25%). While specific components of these pathways or net-
works could represent modifiers of the cancer phenotype, the
results also suggest that influential genetic variation is
broadly dispersed across functional biological pathways. This
conclusion is tempered by acknowledged limitations to these
studies that include the imperfect nature of algorithms used
to determine gene enrichment and the fact that transcript
measurements do not reflect the complete picture of biologi-
cal pathways and networks.
Gene expression variability in the human prostate: 
correlations with cancer phenotype
Having established that consistent measurable differences in
murine prostate gene expression occur in the context of
genetic background, we next sought to determine if the
orthologous genes were also variable in the human prostate,
and whether the underlying normal gene expression levels,
potentially representing quantitative traits, associate with
aspects of human prostate carcinogenesis. We focused on
transcript alterations between the C57BL/6 and FVB/N
strains due to experimental evidence demonstrating that for
the TRAMP model system of prostate cancer, the C57BL/6
genome delays cancer progression relative to an accelerated
rate of carcinogenesis in other strains, including FVB/N [14].
We also focused on transcript differences between the
C57BL/6 and BALB/c strains due to a recent report describ-
ing a reduced incidence of prostate adenocarcinomas in Pten
deficient mice of a 129/C57 background relative to high rates
of prostate carcinomas, up to 90% by 6 months, in Pten defi-
cient mice of a 129/BALB/c background. These studies sug-
gest the hypothesis that genes expressed highly in C57BL/6
prostates might function as inhibitors of carcinogenesis
whereas genes expressed highly in other strains - relative to
C57BL/6 - could function to promote or permit carcinogene-
sis. Direct comparisons of transcript abundance levels from
prostates of the C57BL/6 strain against FVB/N and C57BL/6
against BALB/c identified 237 and 173 genes with significant
differences, respectively (Table 1; Figures 5a and 6a).
We next measured the transcript abundance levels of these
variable murine prostate genes in human prostate tissues.
Based on the TRAMP mouse model data, we hypothesized
that if genes expressed highly in C57BL/6 relative to FVB/N
prostates (designated C57-High) retard aspects of carcino-
genesis, they would be down-regulated in the prostates of
those individuals shown to have aggressive prostate cancers,
and if genes expressed highly in FVB/N relative to C57BL/6
prostates (designated C57-Low) promote aspects of carcino-
genesis, they would be elevated in the prostates of individuals
with aggressive prostate cancers. Similar reasoning was
applied to genes differentially expressed between BALB/c
and C57BL/6 prostates.
We analyzed data reported by Lapointe et al. [26] that gener-
ated independent gene expression profiles from matched
pairs of benign and neoplastic human prostate tissues accom-
panied by pathological criteria of tumor aggressiveness
according to the Gleason grading system. This human dataset
contained orthologs for 113 of the 237 genes with differential
expression in C57BL/6 relative to FVB/N prostates, and 91 of
the 173 genes with differential expression in C57BL/6 relative
to BALB/c prostates. We specifically focused on gene expres-
sion in the benign tissue of each human prostate sample as a
potential measure of an underlying predisposition to cancer
phenotypes reflected by cancer grade: low pathological grade
(Gleason ≤6) versus cancers of higher grade (Gleason 7-10).R117.8 Genome Biology 2007,     Volume 8, Issue 6, Article R117       Bianchi-Frias et al. http://genomebiology.com/2007/8/6/R117
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Clusterin is highly expressed in the FVB/N strain Figure 4
Clusterin is highly expressed in the FVB/N strain. (a) qRT-PCR measurement of Clusterin RNA in prostate preparations used in microarray analysis. White 
bars are the data from the microarray experiments and black bars are values generated by qRT-PCR. (b) Western blot analysis of clusterin in the ventral 
prostates of FVB/N, DBA/2 and C57BL/6 mouse strains. Ventral prostate tissue (pool of three ventral prostates per lane/strain) was prepared and equal 
amounts of protein were resolved by SDS-PAGE and probed with anti-clusterin antibody. Antibody against β-actin was used as a loading control. (c, d) 
Immunohistochemical analysis of paraffin sections from dorsal prostate (DP), lateral prostate (LP), anterior prostate (AP) (c) and ventral prostate (VP) 
lobes (c, d) of 8-9 week old mice from FVB/N, DBA/2 and C57BL/6 strains. Sections were stained with anti-clusterin antibody. Clusterin immunoreactivity 
is most intense in the apical region of the secretory epithelial cells from the ventral prostate (arrow).
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Mouse prostate strain-associated gene expression and analysis in human prostate tissues: FVB/N and C57BL/6 Figure 5
Mouse prostate strain-associated gene expression and analysis in human prostate tissues: FVB/N and C57BL/6. (a) Genes differentially expressed in 
prostates of FVB/N and C57BL/6 strains. Heat map colors reflect fold ratio values between sample and reference pool. Columns 1-4 represent biological 
replicates for each strain. Rows represent individual genes. Values shown in red are relatively larger than the overall mean; values shown in green are 
relatively smaller than the overall mean. (b) Transcript abundance levels in benign human prostate tissues associated with high grade (7-10) or low grade 
(≤6) adenocarcinomas for each gene determined to be altered in mouse strain comparisons where a corresponding ortholog was identified. Genes 
depected in (a) and (b) are in identical order. Black box (b) and text (a) represent genes with significant differential expression in the human datasets 
altered in the expected orientation. Gray box (b) and text (a) represent genes with significant differential expression in the human datasets altered in the 
opposite orientation. (c-e) Transcript alterations for selected genes in benign tissue samples associating with high (Gleason 7-10) and low (Gleason ≤6) 
prostate cancers. Plots represent the 95% confidence intervals of log2 expression ratios of tissues samples relative to a cell line reference.
12341234 ........................................
GLEASON
SCORE 7-10
Strain
FVB C57
GLEASON
SCORE 6
(b) (a)
Sepp1
Slc30a10
Pik3c2g
Tmem100
Esr1
Atp1a1
Slc7a11
Basp1
Rab6
Mcm6
Pabpc1
Srpx
Rbp4
Ppox
Slc25a17
Lsm6
D14Ertd449
Odc1
Tuft1
APOD
6 7-10
0
1
2
3
4
p = 0.001
Gleason Pattern
L
o
g
2
 
R
a
t
i
o
s
 
t
o
 
C
e
l
l
 
L
i
n
e
 
R
e
f
e
r
e
n
c
e TMEM100
6 7-10
-3
-2
-1
0
p = 0.008
Gleason Pattern
L
o
g
2
 
R
a
t
i
o
s
 
t
o
 
C
e
l
l
 
L
i
n
e
 
R
e
f
e
r
e
n
c
e
BASP1
6 7-10
0
1
2
3
p < 0.001
Gleason Pattern
L
o
g
2
 
R
a
t
i
o
s
 
t
o
 
C
e
l
l
 
L
i
n
e
 
R
e
f
e
r
e
n
c
e
G
e
n
e
s
(c) (d) (e)
Apod
Wnt4R117.10 Genome Biology 2007,     Volume 8, Issue 6, Article R117       Bianchi-Frias et al. http://genomebiology.com/2007/8/6/R117
Genome Biology 2007, 8:R117
Mouse prostate strain-associated gene expression and analysis in human prostate tissues: BALB/c and C57BL/6 Figure 6
Mouse prostate strain-associated gene expression and analysis in human prostate tissues: BALB/c and C57BL/6. (a) Genes differentially expressed in 
prostates of BALB/c (BALB) and C57BL/6 (C57) strains. Heat map colors reflect fold ratio values between sample and reference pool. Columns 1-4 
represent biological replicates for each strain. Rows represent individual genes. Values shown in red are relatively larger than the overall mean; values 
shown in green are relatively smaller than the overall mean. (b) Transcript abundance levels in benign human prostate tissues associated with high grade 
(7-10) or low grade (≤6) adenocarcinomas for each gene determined to be altered in mouse strain comparisons where a corresponding ortholog was 
identified. Genes depicted in (a) and (b) are in identical order. Black box (b) and text (a) represent genes with significant differential expression in the 
human datasets altered in the expected orientation. Gray box (b) and text (a) represent genes with significant differential expression in the human datasets 
altered in the opposite orientation. (c-e) Transcript alterations for selected genes in benign tissue samples associating with high (Gleason 7-10) and low 
(Gleason ≤6) prostate cancers. Plots represent the 95% confidence intervals of log2 expression ratios of tissues samples relative to a cell line reference.
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In agreement with this hypothesis, seven genes expressed
highly in C57BL/6 prostates were measured at significantly
lower levels in prostates with high-grade cancers relative to
prostates with low-grade cancers (for example, BASP1) (Fig-
ure 5b-e).
Six genes expressed relatively highly in FVB/N prostates (for
example, ApoD) exhibited significantly higher transcript lev-
els in the prostates containing high-grade cancers relative to
prostates with low-grade cancer (Figure 5). Apolipoprotein D
(APOD) is a member of the lipocalin superfamily of protein
transporters that is implicated in the pathogenesis of neuro-
degenerative diseases and is regulated by androgens in both
breast and prostate cells [27,28]. Studies of prostate cancer
have demonstrated elevated APOD protein levels in prostate
intraepithelial neoplasia and prostate carcinoma [29], but
associations between APOD  polymorphisms, or APOD
expression in benign epithelium in the context of cancer phe-
notypes have not been reported. Two recent studies of the
Drosophila  ApoD ortholog, GLaz, provide context for the
potential influence of ApoD expression on cytoprotection and
cell survival [30,31]. Overexpression of Glaz increased resist-
ance to stresses that included starvation, hyperoxia and
hypoxia, and resulted in the extension of organismal lifespan
[30]. Conversely, loss of GLaz resulted in the reduction of
Drosophila  stress resistance and lifespan, consistent with
APOD being part of a defense system that is activated in the
setting of oxidative stress, or incited by exogenous environ-
mental factors or intrinsic events such as aging or neoplasia
[31].
Counter to our hypothesis, several genes exhibited significant
expression differences inversely associated with the human
prostate cancer grade-status predicted by the mouse pheno-
types. For example, transcript levels of four C57-Low genes
(for example, Esr1) in benign prostate tissues were signifi-
cantly associated with low-grade cancers and five C57-High
genes (for example, Rbp4) were expressed at greater levels in
benign tissue associated with high-grade relative to low-grade
prostate cancers (Figure 5b). Similar results were observed
for genes differentially expressed between BALB/c and
C57BL/6 prostates when evaluated in benign tissues from
prostates with high-grade cancers relative to prostates with
low-grade cancers (Figure 6).
One possible explanation for these findings centers on differ-
ent tumor initiating mechanisms (and pathways) that subse-
quently interact with different intrinsic intracellular and
extracellular 'host' gene expression programs. For example,
although studies of mouse prostate tumorigenesis demon-
strate that the C57 strain appears to reduce tumorigenesis
caused by p53/Rb (TRAMP model) or Pten alterations, the
C57 background increases the development of prostate
intraepithelial neoplasia lesions in mice with targeted dele-
tions of the Nkx3.1 homeobox gene [32], and increases tum-
origenesis in the setting of ras+myc expression, relative to
other strains [33]. Thus, the complexities of the interactions
between different tumor initiating events and host genomes
are likely to be quite complex, a factor that could certainly
influence the interpretation of human data where initiating
events for any particular primary tumor are poorly defined.
As heritable differences provide ample opportunities for
mutations in growth control genes to exert differential effects
depending upon the inherent wiring of the altered cell or the
surrounding micro- and macroenvironment, improved sub-
classifications of human prostate tumors that associate with
specific oncogenenic events, such as the recently reported
TMPRSS2-ERG fusions [34], may assist in defining consist-
ent associations. In support of this concept are data demon-
strating that a polymorphism in the promoter region of the
MDM2  gene enhances MDM2 expression, attenuates p53
tumor suppressor function and accelerates tumor progres-
sion rates of both hereditary and sporadic human cancers
arising in the context of p53 alterations [35].
Conclusion
The quantification of tissue gene expression represents a
measure of phenotypic variation at the molecular level that
can be ascertained as comprehensive profiles reflecting active
biological pathways. Exploiting gene expression information
as quantitative traits (QTL) has facilitated large-scale efforts
to identify genomic loci that contribute to complex pheno-
types and diseases [36]. In this study we have found substan-
tial reproducible gene expression differences in the murine
prostate that associate with genetic background. Large strain-
specific differences in tissue gene expression are not unique
to the prostate. We have previously demonstrated that tran-
script abundance levels in the liver differ between mice of dif-
ferent strains [37]. Studies of strain-dependent differences in
the development and progression of murine breast carcinoma
have delineated gene expression differences in tumors arising
in the context of genetic background [8], but it is likely that
many of these differences were present in the breast tissues
prior to cancer development. Indeed, mouse strains with
high- or low-metastatic genotypes are reportedly
distinguishable using gene expression measurements from
benign breast tissue [38].
These data emphasize that, in addition to the initiating inci-
dent, context may be important for the process of carcinogen-
esis. Importantly, the predisposition to a detrimental
sequence of events leading to pathology might be determined
through assessments of the expression program operative in
the normal state between different individuals. Thus, as with
studies associating disease predisposition with variations in
DNA polymorphisms, copy numbers, and epigenetic marks,
studies of variation in gene expression in benign tissues, opti-
mally with a tissue or cell type-specific focus, could provide
insights into cancer predisposition and gene-environment
interactions.R117.12 Genome Biology 2007,     Volume 8, Issue 6, Article R117       Bianchi-Frias et al. http://genomebiology.com/2007/8/6/R117
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Materials and methods
Animal work and RNA preparation
Male mice 7 weeks of age were purchased from the Jackson
Laboratory (C57BL/6J, 129X1/SvJ and FVB/NJ) or the
Charles River Laboratories (BALB/cAnNCrl and DBA/
2NCrl), maintained in a barrier facility and cared for in
accordance with approved IACUC protocols. Following ship-
ment, mice were acclimated to a common temperature, day-
night cycle, and diet for 12 days to minimize environmental
differences. Twelve mice from each of five strains, C57BL/6J,
129X1/SvJ, FVB/NJ, BALB/cAnNCrl and DBA/2NCrl
(abbreviated C57BL/6, 129X1/Sv, BALB/c, FVB/N and DBA/
2, respectively), were randomized for the day and time of sac-
rifice. Following halothane anesthesia, mice were sacrificed
by cervical dislocation. Prostates were rapidly excised, and
dorsal, lateral, ventral and anterior lobes were separately dis-
sected and snap-frozen in liquid nitrogen and stored at -80°C.
To control for individual variability [39], the dissected pros-
tate lobes from mice of each strain were divided into four
pools of three mice each and combined for total RNA isola-
tion. Prostate tissues were homogenized using a Polytron and
total RNA was isolated using the RNeasy extraction kit (Qia-
gen, Valencia, CA). Due to the limited concentration of total
RNA obtained, specifically from the lateral lobe, equal
amounts of total RNA (0.7 μg) from each of the four pooled
lobes/strain were combined to produce secondary pools, and
amplified with the MessageAmp™ aRNA kit (Ambion, Aus-
tin, TX). Amplified RNA from each secondary pool (four pools
per strain) was hybridized separately to cDNA microarrays
for a total of 4 independent biological replicates per strain (12
mice, 4 pools of 3 mice per strain for a total of 4 microarray
experiments per strain; Figure 1). A common reference sam-
ple was created by combining equal amounts of RNA from all
the samples from all strains.
Probe construction, microarray hybridization and data 
acquisition
The amplified RNA was used as template for cDNA probe syn-
thesis followed by hybridization to a custom mouse prostate
cDNA array (mPEDB array) composed of approximately
8,300 genes expressed in the developing and adult mouse
prostate [40]. The 20 microarrays used for the experiment
were all from the same printing batch. cDNA probes were
made from 2 μg of amplified RNA in a reaction volume of 30
μl containing 170 ng random hexamer primers, 0.2 mM 5-(3-
aminoallyl)-2-deoxyuridine-5-triphosphate (amino acid-
dUTP; Sigma-Aldrich, St. Louis, MO), 0.3 mM dTTP, 0.5 mM
each dATP, dCTP, and dGTP, and 380 units of Superscript II
reverse transcriptase (Invitrogen, Carlsbad, CA) incubated at
42°C for 120 minutes. After RNA hydrolysis, purified cDNA
was combined with either Cy3 or Cy5 monoreactive fluors
(Amersham Pharmacia, Piscataway, NJ) that covalently cou-
ple to the cDNA incorporated aminoallyl linker in the pres-
ence of 50 mM NaHCO3 (pH 9.0). The coupling reaction was
quenched with hydroxylamine and reference and experimen-
tal probes were combined, filtered, and competitively
hybridized to microarrays under a coverslip for 16 h at 63°C.
Slides were washed sequentially with 1× saline sodium citrate
(SSC)/0.03% sodium dodecyl sulfate (SDS), 1× SSC, 0.2×
SSC, 0.05× SSC, and spun dry. To account for dye bias, half of
the biological experimental samples per strain were labeled
with Cy3 dye and the reference with Cy5 dye, and in the other
half the labeling was inversed.
Microarray data collection and analysis
Fluorescent array images were collected for both Cy3 and Cy5
using a GenePix 4000B fluorescent scanner (Axon Instru-
ments, Foster City, CA, USA). The image intensity data were
gridded and extracted using GenePix Pro 4.1 software. For
each array spot, the expression levels of the two fluorophores
were obtained by subtracting median background intensity
from median foreground intensity. A gene was only consid-
ered expressed if the fluorescence intensity of the corre-
sponding spot was at least six foreground pixels greater than
four standard deviations above background in at least half of
the arrays per strain. Array spots not meeting these criteria
were designated NA. For each gene, the logarithm base 2
ratios (referred henceforth as log ratios) of the two channels
were calculated to quantify the relative expression levels of
genes between the experimental and reference samples.
To allow for inter-array comparisons, each array was normal-
ized to remove systematic sources of variation. This was
accomplished by means of a print-tip-specific intensity-based
normalization method [41]. A scatter-plot smoother, which
uses robust locally linear fits, was applied to capture the
dependence of the log ratios on overall log-spot intensities.
The log ratios were normalized by subtracting the fitted val-
ues based on the print-tip-specific scatter-plot smoother from
the log ratios of experimental and control channels. After nor-
malization, spots were removed from further analysis if they
had more then 3 NA values or if they were in the lower third
quantile of abundance across all 20 arrays.
To identify genes that varied among strains of mice, log2 ratio
measurements were statistically analyzed using the SAM pro-
cedure [42]. A multiclass response t-test was used to deter-
mine whether the gene expression of one strain significantly
differed from the other strains giving a moderate estimate of
false positive genes of 10% (FDR). When differences in the
expression of genes were examined using SAM software, 932
genes were statistically differentially expressed across the five
strains of mice. Transcriptional profiles of the five mouse
strains were also compared with average-linkage hierarchical
clustering and Principle Components Analysis (PCA.) Aver-
age linkage hierarchical clustering was used to cluster the
samples using all the genes or only those that were differen-
tially expressed. To further characterize the relationships
between the strains, we performed PCA on the 932 differen-
tially expressed genes. All analyses were done using Biocon-
ductor software [43].http://genomebiology.com/2007/8/6/R117 Genome Biology 2007,     Volume 8, Issue 6, Article R117       Bianchi-Frias et al. R117.13
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Comparisons of mouse prostate and human prostate 
gene expression for association with tumor phenotypes
T o  e v a l u a t e  t r a n s c r i p t  a b u n d a n c e  l e v e l s  i n  b e n i g n  h u m a n
prostate epithelium that associated with cancer grade or
stage, we focused on genes that were differentially expressed
between prostates of C57BL/6 and FVB/N, and between
C57BL/6 and BALB/c mouse strains. Based on studies of the
TRAMP and Pten prostate cancer models, we designated the
C57BL/6 strain as 'prostate cancer-inhibiting' and the FVB/N
and BALB/c strains as 'prostate cancer-permitting'. The SAM
algorithm was used to identify the 237 genes differentially
expressed between C57BL/6-FVB/N and the 173 genes
between C57BL/6-BALB/c strains using a FDR of <5%.
We next investigated whether differences in gene expression
patterns of benign prostate tissues adjacent to prostate can-
cers were associated with Gleason pattern or patient out-
comes. We evaluated a study by Lapointe et al. [26] that
profiled benign tissues matched with prostate adenocarcino-
mas of defined Gleason grades. The data were derived from
spotted cDNA microarrays and we normalized the data by fit-
ting a print-tip specific Lowess curve to the log-intensity ver-
sus log-ratio plot. Normalized log2 ratio data were filtered to
include clones with orthologs to the Mouse Prostate Expres-
sion Database (MPEDB) array. Out of the 237 and 173 genes
that were identified as differentially expressed (q-value of
<5%) between C57BL/6 and FVB/N, and between C57BL/6
and BALB/c, respectively, 113 and 91 had sufficient informa-
tion to test in the Lapointe et al. data. An unpaired two-sam-
ple  t-test was used to determine the association between
expression level in the benign tissue and the corresponding
Gleason pattern cancers adjacent to the normal samples. The
R-code for this analysis can be found online at the MPEDB
website in the supplementary data section [44].
Biological pathway analysis
In order to identify specific biological pathways that exhibit
strain specific variation, we utilized the GST method available
in BioConductor, an algorithm similar to the GSEA method
reported by Subramanian et al. [25]. Briefly, t-statistics com-
paring the expression levels of genes between the C57BL/6
and all other strains were used as input to the GST algorithm.
All other settings were kept at their default status and the
pathways were obtained from the GO database [45]. We
defined a pathway as showing strain-specific variation if its
corresponding FDR was less than 25%.
Microdissection of luminal epithelium
Frozen sections (7 μm) were cut from snap-frozen mouse
prostate glands and immediately fixed in cold 95% ethanol.
After fixing, the slides were washed in deionized RNase-free
water, stained with Mayer's hematoxylin for 30 seconds, fol-
lowed by another water wash. The sections were then dehy-
drated with two one-minute washes in 100% followed by two
five-minute changes in Xylene. Approximately 4,000 luminal
epithelial cells were captured from the ventral, dorsal, lateral
and anterior prostate lobes from 3 independent animals for a
total of 12,000 cells per lobe using the Arcturus PixCell II
instrument (Arcturus, Mountain View, CA, USA). Digital pho-
tos were taken of tissue sections before, during, and after
LCM and assessed independently to confirm the cell type-
specificity of the captured cells. Total RNA was extracted
using the Picopure RNA isolation kit (Arcturus) according to
the manufacturer's specifications. The extracted RNA was
subjected to two rounds of amplification using the Mes-
sageAmpTM aRNA kit (Ambion).
Quantitative RT-PCR
RNA from microdissected epithelium and from preparations
used in the microarray analysis were used as template for
qRT-PCR. We used 200 ng of amplified RNAs or 20 ug of total
RNAs to generate cDNAs. SYBR GREEN real-time PCR was
performed as previously described [39]. Primers to ribosomal
protein S16 were used to normalize cDNA loading. The
sequences of the primers used in this study were: S16 for-
ward, 5'-AGGAGCGATTTGCTGGTGTGGA-3', S16  reverse,
5'-GCTACCAGGCCTTTGAGATGGA-3';  Psca  forward, 5'-
GCCTGGTAGAGGCTGAGATG-3',  Psca  reverse, 5'-
ATCATCTCCTGGGACTCCTG-3';  Clusterin  forward, 5'-
TTTATGGACACAGTGGCGGA-3',  Clusterin  reverse, 5'-
GCTTTTCCTGCGGTATTCCTG-3';  Mmp7  forward, 5'-
CTGATGATGAGGACGCAGGA-3',  Mmp7  reverse, 5'-
ATTCATGGGTGGCAGCAAAC-3';  Svs2  forward, 5'-TCA-
GAAAGGCCGTCTCAGTT-3',  Svs2  reverse, 5'-AGCTGCT-
TCGTCACTTCCTC-3';  Sbp  forward, 5'-
TGGAAACGATGATGATGACC-3', Sbp reverse, 5'-TGTGGA-
GATGCAGGACTGAG-3'.
Western blot analysis
Prostates from three animals per strain were rapidly excised,
and ventral lobes were separately dissected. Protein extracts
were prepared by homogenizing and sonicating each ventral
prostate lobe in 500 μl of T-PER buffer (Pierce Biotechnol-
ogy, Rockford, IL, USA) and a cocktail of protease inhibitors
(Roche, Indianapolis, IN, USA). Pooled ventral lobe lysates
(50 μg) were separated by SDS-PAGE followed by western
blot analysis using antibodies recognizing clusterin (M-18,
Santa Cruz Biotechnology, Santa Cruz, CA, USA) and actin (I-
19, Santa Cruz) at 1:200 and 1:400 dilutions, respectively.
Immunohistochemistry
Formalin-fixed, paraffin-embedded mouse prostate tissue
sections were deparaffinized, and endogenous peroxidase
activity was blocked with 3% H2O2 for 5 minutes. Antigen was
retrieved by steam heating with 10 mM citrate buffer (pH 6.0)
for 20 minutes. For the detection of clusterin, a rabbit poly-
clonal anti-clusterin antibody (H330; Santa Cruz Biotechnol-
ogy) was used at 1:1,000 dilution in blocking solution, and the
sections were incubated for 1 h at room temperature. After
washing, the slides were incubated for 30 minutes with bioti-
nylated species-specific secondary antibody diluted 1:500
(Vector Laboratories, Burlingame, CA, USA), washed, thenR117.14 Genome Biology 2007,     Volume 8, Issue 6, Article R117       Bianchi-Frias et al. http://genomebiology.com/2007/8/6/R117
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incubated with avidin-peroxidase complex (ABC, Vector Lab-
oratories) for 30 minutes and visualized using VIP peroxidase
substrate (Vector Laboratories). The sections were dehy-
drated, and permanently mounted. Species-specific IgG iso-
types were added in lieu of primary antibody as controls, and
these sections demonstrated no detectable staining. The
expression of clusterin was assessed in four independent ani-
mals per strain.
Tissue morphometry
To evaluate the percentage of each prostate lobe occupied by
stroma, two formalin-fixed, paraffin-embedded prostates per
strain were serially cut to generate 5 μm sections spaced 30
μm apart. Sections were stained with hematoxylin and eosin
and the total tissue areas and stroma areas were separately
calculated from each prostate lobe using ImageJ image anal-
ysis software [46]. Six measurements were taken from each of
the four lobes for each of the five strains. To determine overall
differences between strains, we fit the following model:
Yijk = μ + Straini + Lobej + εk
where Yijk is the percentage of stroma area observed from
mouse K, lobe j, strain i.
Data
Microarray data for this study have been deposited in the
Gene Expression Omnibus [47] under accession GSE5962.
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